Qiming Corporate GP III, Ltd. - Net Worth and Insider Trading

Qiming Corporate GP III, Ltd. Net Worth

The estimated net worth of Qiming Corporate GP III, Ltd. is at least $321 Million dollars as of 2024-06-23. Qiming Corporate GP III, Ltd. is the 2201 Interest of corporation controlled by you of Venus Medtech (Hangzhou) Inc and owns about 57,048,980 shares of Venus Medtech (Hangzhou) Inc (HKSE:02500) stock worth over $321 Million. Details can be seen in Qiming Corporate GP III, Ltd.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Qiming Corporate GP III, Ltd. has not made any transactions after 2023-01-17 and currently still holds the listed stock(s).

Transaction Summary of Qiming Corporate GP III, Ltd.

Qiming Corporate GP III, Ltd. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Qiming Corporate GP III, Ltd. owns 1 companies in total, including Venus Medtech (Hangzhou) Inc (HKSE:02500) .

Click here to see the complete history of Qiming Corporate GP III, Ltd.’s form 4 insider trades.

Insider Ownership Summary of Qiming Corporate GP III, Ltd.

Ticker	Comapny	Transaction Date	Type of Owner
HKSE:02500	Venus Medtech (Hangzhou) Inc	2023-01-17	2201 Interest of corporation controlled by you

Qiming Corporate GP III, Ltd. Latest Holdings Summary

Qiming Corporate GP III, Ltd. currently owns a total of 1 stock. Qiming Corporate GP III, Ltd. owns 57,048,980 shares of Venus Medtech (Hangzhou) Inc (HKSE:02500) as of January 17, 2023, with a value of $321 Million.

Latest Holdings of Qiming Corporate GP III, Ltd.

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
HKSE:02500	Venus Medtech (Hangzhou) Inc	2023-01-17	57,048,980	5.62	320,615,268

Holding Weightings of Qiming Corporate GP III, Ltd.

Qiming Corporate GP III, Ltd. Form 4 Trading Tracker

According to the SEC Form 4 filings, Qiming Corporate GP III, Ltd. has made a total of 2 transactions in Venus Medtech (Hangzhou) Inc (HKSE:02500) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Venus Medtech (Hangzhou) Inc is the sale of 327,000 shares on January 17, 2023, which brought Qiming Corporate GP III, Ltd. around $6 Million.

Insider Trading History of Qiming Corporate GP III, Ltd.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Qiming Corporate GP III, Ltd. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Qiming Corporate GP III, Ltd. Ownership Network

Ownership Network List of Qiming Corporate GP III, Ltd.

No Data

Ownership Network Relation of Qiming Corporate GP III, Ltd.

Qiming Corporate GP III, Ltd. Owned Company Details

What does Venus Medtech (Hangzhou) Inc do?

Who are the key executives at Venus Medtech (Hangzhou) Inc?

Qiming Corporate GP III, Ltd. is the 2201 Interest of corporation controlled by you of Venus Medtech (Hangzhou) Inc. Other key executives at Venus Medtech (Hangzhou) Inc include 2201 Interest of corporation controlled by you Zeng Min Frank , 2201 Interest of corporation controlled by you Zi Zhenjun , and 2101 Beneficial owner Ming Zhi Investments (bvi) Limited .

Venus Medtech (Hangzhou) Inc (HKSE:02500) Insider Trades Summary

Over the past 18 months, Qiming Corporate GP III, Ltd. made 1 insider transaction in Venus Medtech (Hangzhou) Inc (HKSE:02500) with a net sale of 327,000. Other recent insider transactions involving Venus Medtech (Hangzhou) Inc (HKSE:02500) include a net purchase of 446,500 shares made by Zi Zhenjun , a net sale of 327,000 shares made by Qiming GP III, L.P. , and a net sale of 158,879 shares made by Qiming Venture Partners III, L.P. .

In summary, during the past 3 months, insiders sold 0 shares of Venus Medtech (Hangzhou) Inc (HKSE:02500) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,130,637 shares of Venus Medtech (Hangzhou) Inc (HKSE:02500) were sold and 446,500 shares were bought by its insiders, resulting in a net sale of 684,137 shares.

Venus Medtech (Hangzhou) Inc (HKSE:02500)'s detailed insider trading history can be found in Insider Trading Tracker table.

Venus Medtech (Hangzhou) Inc Insider Transactions

No Available Data

Qiming Corporate GP III, Ltd. Mailing Address

Above is the net worth, insider trading, and ownership report for Qiming Corporate GP III, Ltd.. Currently GuruFocus does not have mailing address information for Qiming Corporate GP III, Ltd..

Discussions on Qiming Corporate GP III, Ltd.

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.